This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates-revisions: Archive
Is Disney (DIS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Disney (DIS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DISNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Earnings Estimates Moving Higher for Betterware de Mexico SAPI de C (BWMX): Time to Buy?
by Zacks Equity Research
Betterware de Mexico SAPI de C (BWMX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
BWMXNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CYRXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Celestica (CLS) Upgraded to Buy: Here's Why
by Zacks Equity Research
Celestica (CLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CLSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Intellicheck Mobilisa (IDN) Rating Upgrade to Strong Buy
by Zacks Equity Research
Intellicheck Mobilisa (IDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
IDNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
BGSF (BGSF) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
BGSF (BGSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BGSFPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Tokio Marine (TKOMY) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Tokio Marine (TKOMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TKOMYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LFSTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
DGXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Dorian LPG (LPG) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Dorian LPG (LPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LPGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Mitsubishi (MSBHF) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Mitsubishi (MSBHF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
MSBHFPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Paysafe Limited (PSFE) Rating Upgrade to Strong Buy
by Zacks Equity Research
Paysafe Limited (PSFE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PSFENegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Wall Street Analysts See a 34.26% Upside in MongoDB (MDB): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 34.3% upside potential for MongoDB (MDB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MDBNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Quanex (NX) Could Surge 95.46%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 95.5% upside potential for Quanex (NX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
NXNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Brokers Suggest Investing in AGNC Investment (AGNC): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AGNC Investment (AGNC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AGNCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Veeva (VEEV) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VEEVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is JD.com (JD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for JD.com (JD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in CyberArk (CYBR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CyberArk (CYBR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CYBRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
MongoDB (MDB) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for MongoDB (MDB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MDBNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About GigaCloud Technology Inc. (GCT): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in GigaCloud Technology Inc. (GCT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
GCTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in PDD Holdings Inc. Sponsored ADR (PDD): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), PDD Holdings Inc. Sponsored ADR (PDD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PDDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is CRISPR Therapeutics (CRSP) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CRISPR Therapeutics (CRSP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRSPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Dorian LPG (LPG): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Dorian LPG (LPG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LPGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Zoetis (ZTS) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Zoetis (ZTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ZTSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Compared to Estimates, Nike (NKE) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Nike (NKE) give a sense of how its business performed in the quarter ended May 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
NKEPositive Net Change
earnings earnings-estimates-revisions earnings-surprise